Correlation between plasma concentration ratios of SN-38 glucuronide and SN-38 and neutropenia induction in patients with colorectal cancer and wild-type UGT1A1 gene

By Hirose Koichi   Kozu Chihiro   Yamashita Koshiro   Maruo Eiji   Kitamura Mizuho   Hasegawa Junichi   Omoda Kei   Murakami Teruo   Maeda Yorinobu  

Oncology Letters, Vol. 3, Iss. 3, 2012-03 ,pp. : 694-698

Spandidos Publications

Access to resources Recommend Favorite

Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells

By Tanaka Tetsuji   Bai Tao   Toujima Saori   Utsunomiya Tomoko   Matsuoka Toshihide   Kobayashi Aya   Yamamoto Madoka   Sasaki Noriyuki   Tanizaki Yuko   Utsunomiya Hirotoshi   Tanaka Junko   Yukawa Kazunori  

Oncology Reports, Vol. 27, Iss. 4, 2012-04 ,pp. : 1292-1298

Spandidos Publications

Access to resources Recommend Favorite

Differential activity of topotecan, irinotecan and SN-38 in fresh human tumour cells but not in cell lines

By Jonsson E.   Dhar S.   Jonsson B.   Nygren P.   Graf W.   Larsson R.  

European Journal of Cancer, Vol. 36, Iss. 16, 2000-10 ,pp. : 2120-2127

Elsevier

Access to resources Recommend Favorite

Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines

By Sarcar Bhaswati   Kahali Soumen   Chinnaiyan Prakash  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 201-207

Springer Publishing Company

Access to resources Recommend Favorite

Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan

By Guemei Aida A.   Cottrell Jeff   Band Roger   Hehman Hilary   Prudhomme Mike   Pavlov Michael V.   Grem Jean L.   Ismail Abdel Salam   Bowen Donnell   Taylor Robert E.   Takimoto Chris H.  

Cancer Chemotherapy and Pharmacology, Vol. 47, Iss. 4, 2001-04 ,pp. : 283-290

Springer Publishing Company

Access to resources Recommend Favorite